Back
Miscellaneous
In this section we cover the importance of antibiotic prophylaxis, impart knowledge
about the effects of addictive substances, emphasize on the calculation of dose
and the normal laboratory values which are helpful in assessing the patient's medical
status, prescription abbreviation and the importance of writing the prescription.
The medico-legal and ethical principles upon which the practice of dentistry is
based, especially those relating to treatment of patients are also indicated.
Antibiotic Prophylaxis
The goal of antibiotic therapy is to aid the body's defence to clear the tissues
of microbial pathogens by achieving antibiotic level in the infected area equal
to or greater than the MIC (minimum inhibitory concentration).
Prevention of Bacterial Endocarditis
Dental procedures where endocarditis prophylaxis is recommended
- Dental extractions.
- Periodontal procedures- surgery, scaling and root planing,
probing and recall maintenance.
- Endodontic instrumentation or surgery beyond
the apex.
- Sub-gingival placement of antibiotic fibres or strips.
- Initial
placement of orthdontic bands and not brackets.
- Intraligamentary local anaesthetic
injections.
- Prophylactic cleaning of teeth or implants where bleeding is anticipated.
Dental procedures where endocarditis prophylaxis is not recommended
- Restorative dentistry (operative, prosthodontic) with or without retraction cords.
-
Local anaesthetic injections (non-intraligamentary).
- Intracanal endodontic treatment.
- Placement of rubber dam, removable prosthodontic
or orthodontic appliance.
- Postoperative suture removal.
- Taking oral
impressions, radiographs.
- Shedding of primary teeth.
Prophylactic regimens for dental procedures
|
Standard
|
Agent
|
Regimen
|
|
Standard general procedures
|
Amoxicillin
|
Adults: 2.0g orally 1hr before procedure; Pediatric: 50mg/kg orally 1 hr before
procedure
|
|
Unable to take oral medications |
Ampicillin |
Adults: 2.0g I.M. or I.V. within 30 mins before procedure; Pediatric: 50mg/kg I.M.
or I.V. within 30 mins before procedure. |
|
Allergic to penicillin |
Clindamycin or Cephelexin or Azithromycin |
(Clindamycin) Adults: 600mg orally 1hr before procedure; Pediatric: 20mg/kg orally
1hr before procedure. (Cephalexine) Adults: 2.0g orally 1hr before procedure; Pediatric:
50mg/kg orally 1hr before procedure. (Azithromycin) Adults : 500mg orally 1hr before
procedure; Pediatric: 15mg/kg orally 1hr before procedure. |
|
Allergic to penicillin and Unable to take oral medications |
Clindamycin or Cefazoline |
(Clindamycin) Adults: 600mg I.V. within 30mins before procedure; Pediatric: 20mg/kg
I.V. within 30mins before procedure. (Cefazoline).Adults: 1.0g im or I.V. within
30mins before procedure; Pediatric: 25mg/kg I.M. or I.V. within 30mins before procedure. |
Prophylaxis for dental patients with Total Joint Replacement
For the first two years after a joint replacement, all patients may need antibiotics
for all high-risk dental procedures. After two years, only high- risk patients may
need to receive antibiotics for high-risk procedures.
Incidence stratification of Bacteremic Dental Procedure
Higher Incidence
- Dental extractions.
- Periodontal procedures including surgery, sub gingival placement of antibiotic fibres/strips,
scaling and root planing.
- Dental implant placement and replantation of avulsed
tooth.
- Endodontic instrumentation.
- Initial placement of orthodontic bands and not brackets.
- Intraligamentary
and intraosseous local anaesthetic injections.
- Prophylactic cleaning of teeth
or implants where bleeding is anticipated.
Lower incidence
- Restorative dentistry (operative, prosthodontic) with or without retraction cords.
- Local anaesthetic injections (nonintraligamentary and intraosseous).
- Intracanal
endodontic treatment.
- Placement of rubber dam, removable prosthodontic or orthodontic
appliance.
- Postoperative suture removal.
- Taking oral impressions, radiographs.
-
Shedding of primary teeth.
Suggested antibiotic prophylaxis regimen
|
Patient type
|
Regimen
|
|
Patients not allergic to penicillin: Cephalexin, Cephradine or amoxicillin. |
2g orally 1hr prior to dental procedure |
|
Patient not allergic to penicillin and unable to take oral medications: Cefazolin
or Ampicillin |
Cefazolin 1g or Ampicillin 2g I.M. or I.V. 1hr prior to the dental
procedure |
|
Patient allergic to penicillin:clindamycin |
600mg orally 1hr prior to the dental procedure |
|
Patient not allergic to penicillin and unable to take oral medications: Clindamycin |
600mg I.V. 1hr prior to dental procedure |
Herbs and Dental Health
Many drugs used in dentistry have their origin in the plant world. Lidocaine and
novocaine, derived from cocoa plant (erythroxylum coca); opiods from poppy (papever
somniferum); Clove oil which contains eugenol is essential oil of Eugenia caryophyllus;
thymol from thyme (thymus vulgaris); are a few to mention.
Chewing sticks as miswak (s.persica) are commonly used in South Asian countries.
Studies have suggested that miswak users have shown significant low dental calculus
in the posterior sextant but fails in the anterior region.
Camelia and other plant are rich in fluoride. Fagara zanthoxyloides and massularia
acuminata reduces acid production and bacterial growth.
Commercial toothpastes have been made from neem (azadiracta indica) and arak (s.persica).
Powdered plant used in abrasive dentrifrices include sweet flag root, gum resin
of myrrh, yellow dock root.
Essential oils of plants are used in commercial mouthwashes. Ex: Listerene uses
thymol, menthol, eucalyptus and methyl salicylate all derived from plants.
Normal Laboratory Values in Adults
Haematologic Examinations
|
Examination
|
Range
|
|
Blood cells |
|
|
Erythrocytes(rbc)(per mm cube) |
|
|
Men |
4.1-5.9 lakhs |
|
Women |
3.8-5.5 lakhs |
|
Leukocytes(WBC)(per mm cube |
4100-12300 |
|
Differential leukocyte count |
|
|
Segmented Neutrophils |
2500-6000 (40-60%) |
|
Band Neutrophils |
0-500 (0-5%) |
|
Juvenile Neutrophils |
0-100 (0-1%) |
|
Myelocytes |
0 (0%) |
|
Lymphocytes |
1000-4000 (15.6-46.6%) |
|
Monocytes |
200-800 (2.8-12.9%) |
|
Eosinophils |
50-300 (0-6%) |
|
Basophils |
0-100 (0-2.3%) |
|
Platelets |
140,000-450,000 |
|
Haemoglobin(hb)(g/100ml) |
|
|
Men |
13-17.5 |
|
Women |
11.6-16.2 |
|
Mean corpuscular Haemoglobin(MCH)(pg/cell) |
28-33 |
|
Mean corpuscular Haemoglobin concentration(MCHC)(g/dl)
|
32-36 |
|
Mean corpuscular volume(MCV)(MMcube) |
86-98 |
|
Haemoglobin, total glycolated(%) |
4.0-8.0 |
|
Haematocrit(Hct)(%) |
|
|
Men |
40-52 |
|
Women |
35-47 |
|
Erythrocyte sedimentation rate(ESR)(mm/hr) |
|
|
Men |
1.0-13 |
|
Women |
1.0-20 |
|
Coagulation Screening Test |
|
|
Bleeding time |
3-9 mins |
|
Coagulation time(Lee-White)(glass) |
5-15 mins |
|
Prothrombin time |
less than 2 mins deviation from control |
|
Thrombin time |
+ or - 5secs of control |
|
Activated partial thromboplastin time(aPTT) |
25-37 secs |
Chemical Constituents of Blood
|
Constituent
|
Range
|
|
Proteins(g/100ml) |
|
|
Total Serum Protein |
6.0-8.4 |
|
Albumin, serum |
3.5-5.0 |
|
Globulin, serum |
2.3-3.5 |
|
A/G ratio |
1.5: 1-3.1 |
|
Lipids (mg/dl) |
|
|
Cholesterol |
|
|
Men |
140-284 |
|
Women |
140-252 |
|
HDL cholesterol |
40-60 |
|
LDL cholesterol |
65-170 |
|
Triglycerides |
30-170 |
|
Enzymes |
|
|
Amylase |
4-25U/ml |
|
Creatinine phosphokinase= CPK (mU/ML) |
|
|
Men |
5.0-55 |
|
Women |
5.0-35 |
|
Lactate Dehydrogenase-LDH (IU/ML) |
|
|
Men |
86-272 |
|
Women |
82-249 |
|
Aspartate transaminase (AST)(SGOT)(I/ML) |
|
|
Men |
6.0-37 |
|
Women |
5.0-37 |
|
Alaine transaminase (ALT)(SGPT)(I/ML) |
|
|
Men |
6.0-46 |
|
Women |
5.0-37 |
|
Phosphatase (alkaline) |
31-121IU/ml |
|
Urea nitrogen (BUN) |
|
|
Urea nitrogen |
4-24mg/100ml |
|
Uric acid |
|
|
Men |
2.4-8.7 |
|
Women |
2.1-6.9 |
|
Creatinine (mg/100ml) |
|
|
Men |
0.5-1.3 |
|
Women |
0.4-1.2 |
|
BUN/Creatinine |
|
|
BUN/Creatinine |
7.0-20 |
|
Oxygen saturation (arterial) |
|
|
Oxygen saturation arterial |
96-100% |
|
PO2 |
|
|
PO2 |
75-100 mmHg |
|
PCO2 |
|
|
PCO2 |
35-45mmHg |
|
CO2 Combining power
|
|
|
CO2 Combining power |
24-34mEq/L |
|
pH |
|
|
pH |
7.35-7.45 |
|
Electrolyte And Inorganic Constituents |
|
|
Chloride (cl-serum) |
94-111mEq/L |
|
Sodium (serum) |
135-145mEq/L |
|
Potassium (serum) |
3.5-5.0mEq/L |
|
Calcium (serum) |
4.3-5.3 mEq/L |
|
Phosphorus (serum)(mg/100ml) |
|
|
Adults |
2.3-5.1 |
|
Children |
4-6.5 |
|
Iron total |
50-150mEq/L |
|
Glucose |
|
|
Glucose, Fasting |
70-110mg/100ml |
|
Bilirubin (mg/100ml) |
|
|
Total |
0.3-1.2 |
|
Direct |
0.0-0.2 |
Urine Analysis
|
Component
|
Range
|
|
Macroscopic |
|
|
Colour |
clear yellow |
|
Specific Gravity |
1.010-1.025 |
|
pH |
4.8-7.5 |
|
Microscopic |
|
|
Bacteria |
0 |
|
Leukocyte |
0-few (single specimen) to 1,800,000/24hrs
|
|
Erythrocyte |
0-few (single specimen) to 500,000/24hrs |
|
Cast |
0 (single specimen) to 5,000/24hrs |
|
Chemical components |
|
|
Glucose |
0 (single specimen) <100mg/dl (25hr specimen)
|
|
Albimin |
0 (single specimen) 10-150mg/24hrs |
|
Ketones |
0 (single specimen) <50mg/24hrs |
|
Creatinine clearance |
150-810L/day/1.73m2 surface area |
Substance Use Disorders
It is important that the dentist be aware of a patient's substance use history.
Some patients may not reveal their history of substance abuse out of shame or fear
of judgement or because they fail to understand the importance of this information
in their treatment.
The following table shows dental implications for people suffering from substance
abuse.
|
Abused substance
|
Facts to aid in diagnosis
|
Drugs that may interact
|
Dental implication
|
|
Alcohol |
|
|
Patient may appear drunk or drowsy and have slurred speech. Odour of alcohol, mouthwash,
fruity acetone may be present. Patient may have difficulty keeping head steady.
|
CNS depressants enhance alcohol induced respiratory depression. Metronidazole reacts
with alcohol to produce flushing, hypotension, nausea and vomiting. |
Alcohol-containing mouthrinses and liquid medications that contain high concentration
of alcohol should be avoided in dental treatment of recovering alcoholics. Recovering
alcoholics with liver disease may require low doses of medications containing acetaminophen
Periodontal disease may not respond to treatment.
|
|
Benzodiazepines (alprozolam, clonazepam) |
|
|
|
CNS depressants are favourites among drug abusers. |
Benzodiazepines may enhance opioid induced respiratory depression. |
Dose of opioids should be reduced to avoid enhanced respiratory depression. Xerostomia
is frequent side effect.
|
|
Barbiturates and gammahydroxybuterates |
|
|
Patient may appear to be drunk or drowsy and have slurred speech. Patient may have
difficulty head keeping head steady. |
CNS depressants may enhance barbiturate induced respiratory depression. |
Dose of opioids should be reduced to avoid enhanced respiratory depression. |
|
Cocaine |
|
|
Patient may act jittery, irritable, unable to sit still. Patient may exhibit tremors
dilated pupils, increased blood pressure and heart rate. |
IV injection of LA containing vasoconstrictor may enhance cocaine induced increased
blood pressure and heart rate. |
Measure blood pressure pre- op and if high postpone the treatment. If the patient
is suspected of use of these drugs within 6hrs, avoid the use of LA containing vasoconstrictor. |
|
Amphetamine |
|
|
Patient may act jittery, irritable, unable to sit still. Patient may exhibit tremors
dilated pupils, increased blood pressure and heart rate |
IV injection containing LA vasoconstrictor may enhance amphetamine induced increased
blood pressure and heart rate. |
Measure blood pressure pre- op and if high postpone the treatment. If the patient
is suspected of use of these drugs within 24hrs, avoid the use of LA containing
vasoconstrictor. |
|
Opioids |
|
|
Patient may appear drowsy, lethargic, disoriented, confused and pupils may be constricted. |
CNS depressants may enhance opioid induced respiratory depression. |
Avoid prescribing opioids analgesics postoperatively in patients recovering from
opioids addiction. Opioids users exhibit profound xerostomia with increased craving
for sweet. |
Length of time drug abuse can be detected in urine
|
Alcohol
|
7-12 hr
|
|
Amphetamine |
48 hr |
|
Methamphetamine
|
48 hr |
|
Barbiturate |
|
|
Short-acting (eg, pentobarbital)
|
24 hr |
|
Long-acting (eg, phenobarbital)
|
3 wk |
|
Benzodiazepine |
|
|
Short-acting (eg, lorazepam)
|
3 days |
|
Long-acting (eg, diazepam) |
30 days |
|
Cocaine metabolites
|
2-4 dayw |
|
Marijuana |
|
|
Single use
|
3 days |
|
Moderate use (4 times/wk) |
5-7 days |
|
Daily use
|
10-15 days |
|
Long-term heavy smoker |
>30 days |
|
Opioids |
|
|
Codeine |
48 hr |
|
Heroin (morphine)
|
48 hr |
|
Hydromorphone
|
2-4 days |
|
Methadone
|
3 days |
|
Morphine
|
48-72 hr |
|
Oxycodone
|
2-4 days |
|
Propoxyphene
|
6-48 hr |
Cessation of Tobacco Use
Dentists can play an important role in making people aware of the ill effects of
tobacco.They are the first health care providers exposed to the signs and symptoms
of oral cancer and other disease that are caused by the use of either smoked or
smokeless tobacco.
The following are the drugs used to aid in tabacco cessation:
Signs and Symptoms may include; Oral sores that do not heal, red or white patches
on the oral mucosa, lumps in the head and neck region, difficulty in chewing and
swallowing or making tongue or jaw movements.
|
Name
|
Indications
|
Dosage
|
Interactions with other agents
|
Contraindications
|
|
Centrally acting Non-Nicotine Agent |
|
Bupropion |
As a part of comprehensive behavioural tobacco use cessation program, to relieve
nicotine withdrawal symptom |
Adults :>=18yrs; initial : 150 mgqd for 3 days; usual:
150mg b.i.d separate dose interval by 8hrs; max: 300mg/day. Initiate the treatment
when the patient is still smoking. |
Contraindicated with MAO inhibitors, other medication containing bupropion, alcohol,
antipsychotic drugs, hepatic enzymes inducers and inhibitors; such agents may inhibit
bupropion metabolism so that their plasma level increases thereby increasing the
risk of seizures. |
Contraindicated in patients with anorexia, bipolar disorders, CNS tumours, head
trauma, history of drug abuse, recent history of myocardial infarct. Contraindicated
with MAO inhibitors and patients sensitive to bupropion. |
|
Varenciline |
As a part of comprehensive behavioural tobacco use cessation program to relieve
nicotine withdrawal symptom. |
Adults>= 18yrs; Days 1-3: 0.5 mg daily, days 4-7: 0.5mg bid, day 8 to end
of treatment: 1mg bid. |
Reduced renal clearance with cimetidine.
|
Tobacco-use cessation,
with or without nicotine replacement may require adjustment of doses of other medication. |
|
Nicotine Inhalation System |
|
Nicotine Inhalation System |
As a part of comprehensive behavioural tobacco use cessation program to relieve
nicotine withdrawal symptom. |
Adults>= 18yrs;
initial: atleast 6 cartridge per day for 3-6 weeks; usual; 6-16 cartridges / day;
max: 16 cartridges/day for 12 weeks. Best effect achieved by frequent puffing, continue
for 3 months. Wean by gradual reduction. |
Should not be used with tobacco products owing to the risk of nicotine toxicity.
Tobacco-use cessation, with or without nicotine replacement may require adjustment
of doses of other medication. |
Contraindicated for continuous use for 6 months, in patients having asthma or chronic
nasal disorders, patients with immediate post myocardial infarction, with severe
dysarrythmia or severe angina pectoris. |
|
Nicotine Nasal Spray |
|
Nicotine Nasal Spray |
As a part of comprehensive behavioural tobacco use cessation program to relieve
nicotine withdrawal symptom. |
Adults>= 18 trs: initial: 2-4 sprays/hr upto 10 sprays /hr for upto 8 wks; min:
16 sprays/day; max: 80 sprays/day. Do not treat for more than 3 months. |
Should not be used with tobacco products owing to risk of nicotine toxicity. Tobacco-use
cessation,
with or without nicotine replacement may require adjustment of doses of other medication. |
Contraindicated for continuous use for 6 months, in patients having asthma or chronic
nasal disorders, patients with immidiate post myocardial infarction, with severe
dysarrythmia or severe angina pectoris. |
|
Nicotine Gums |
|
Nicotine gum |
As a part of comprehensive behavioural tobacco use cessation program to relieve
nicotine withdrawal symptom. |
Stop smoking completely before use. <25cigarettes/day: use 2mg, >25cigarettes/day:
use 4mg. Chew 1 piece for 30mins; 1-2hr for 6 wks, then 1 piece; 2-4hr 3wks, then
1 piece 4-8 hrs 3wks. Max 24 pieces /day and 12 wks of therapy.Chew atleast 9 pieces/day.
Gum should be chewed until tingling is felt. |
Should not be used with tobacco products owing to risk of nicotine toxicity.Tobacco-use
cessation, with or without nicotine replacement may require adjustment of doses
of other medication. Do not eat or drink 15 minutes before, during and after use. |
Contraindicated in non- smokers, immediate post myocardial infarction period, with
severe dysarrythmia or severe angina pectoris. Gum is contraindicated for patients
who ware prosthesis or with TMJ disorder. |
|
Transdermal Nicotine System |
|
Nicotine Transdermal Patches |
As a part of comprehensive behavioural tobacco use cessation program to relieve
nicotine withdrawal symptom. |
Depending on the stage of patients health, weight and level of nicotine dependency,
dosage can range from 7- 22mg/day. The entire course requires 6-8 weeks. |
Should not be used with tobacco products owing to risk of nicotine toxicity.Tobacco-use
cessation, with or without nicotine replacement may require adjustment of doses
of other medication. The following agents may require decreased dose of nicotine
on cessation of tobacco use- acetaminophen,
adrenergic antagonists,caffiene
, insulin, pentazosine. |
Contraindicated for continuous use >3months. Patients with immediate post myocardial
infarction, with severe dysarrythmia or severe angina pectoris. Patients who have
hypersensitivity to any component on therapeutic system. |
Weights and Measures
Common metric measurements and their abbreviations.
|
Metric measurements
|
Abbreviations
|
|
Weight |
|
gram |
g |
|
kilogram |
kg |
|
milligram |
mg |
|
microgram |
mcg |
|
Volume |
|
litre |
L |
|
millilitre |
ml |
Common Metric Equivalent
|
Metric measurements
|
Equivalent
|
|
Weight |
|
0.001g |
1milligram |
|
1gm |
1,000milligram |
|
1kg |
1,000gms |
|
Volume |
|
1ml |
0.001 litre |
|
1,000ml |
1L |
Measures of Volume
|
Metric measurements
|
Apothecary
|
|
5milliliters
|
1 teaspoonful
|
|
30mL
|
1 fluid ounce
|
|
480mL |
1pint |
|
960mL |
1quart |
Measures of Weight
|
Metric measurement
|
Apothecary
|
|
1gram
|
15 grains
|
|
30gms
|
1 ounce
|
|
1kg |
2.2 pound |
Sample Prescriptions and Prescription Abbreviations
A prescription is a written or verbal order for medication to be used for the diagnosis,
prevention or treatment of a specific patient disease by a licensed physician, dentist
or veterinarian.
Sample Prescription
1) Rx
Amoxicillin 500mg
Dispense 4 capsules
Sig:Take 2 tablets with water 1 hr before the dental appointment
Substitution: permitted
not permitted
|
|
Signature
|
|
|
|
|
Refill: 0x 1x 2x 3
|
DEA:
|
2) Rx
Sodium fluoride oral solution 0.5 mg flouride/1ml
Dispense 50 ml
Sig: Give one half dropper ful once daily
Substitution: permitted
not permitted
|
|
Signature
|
|
|
|
|
Refill: 0x 1x 2x 3
|
DEA: |
Prescription abbreviations
|
Term (latin) |
Abbreviation
|
Meaning
|
|
RX |
RX |
receive |
|
ante cibum |
ac |
before meals |
|
post cibum |
pc |
post meals |
|
pro re nata |
prn |
as needed |
|
quaqe 3 hora |
q3h |
every 3rd hourly |
|
bis in die |
b.i.d |
two times a day |
|
ter in die |
t.i.d |
three times a day |
|
quarter in die |
q.i.d |
four times a day |
|
quaqe die |
q.d |
everyday |
|
quaqe hora |
qh |
every hour |
|
per os |
po |
by mouth |
|
oculus dexter |
od |
right eye |
|
oculus sinister |
os |
left eye |
|
quaqe alternis die |
qod |
every other day
|
|
|
amp |
ampule |
|
|
iv |
intravenous |
|
capsula |
cap |
capsule |
|
tabella |
tab. |
tablet |
|
dispensa |
disp. |
dispense |
|
signa |
sig |
label |
|
stat |
statim |
Immediately |
Legal Implications of using Drugs in Dentistry
Choosing dental products that are Food Safety and Standards Authority of India and/or
IDA approved, is a wise choice concerning their safety and efficacy for approved
uses. However, the dentist must show that the product was indicated by a particular
patients needs. Uses of approved dental products in non-approved ways or use of
non-approved products may be considered as negligence in some malpractice actions,
but allowed under standards of resonableness in other situations. The dentist must
be able to justify decisions on a scientific basis.
Calculation of Paediatric Doses
Paediatric doses based on formal experiments or the experience of the prescriber
are better than those calculated according to a general rule or formula.
Unfortunately, optimal paediatric doses have not been established for most drugs.
Thus, where possible, doses for younger children and especially for infants, should
be learned as such and not based merely on a formula; doses calculated with a formula
(as a fraction of the adult dose based on the body weight or body surface area)
are very unreliable for premature infants, but more reliable for children at least
2 years old.
Dosage rules involving a fraction of the adult dose
a) A General Rule of Dosage
|
Age (in years)
|
Dose
|
|
20 yrs or older
|
Adult dose
|
|
10 yrs |
1/2 the average adult dose |
|
5 yrs |
1/4the average adult dose |
|
21/2 yrs |
1/8 the average adult dose |
|
1 yr |
1/12 the average adult dose |
b) Clark's Rule
Weight of child(lb)
150
|
X Adult dose |
c) Young's Rule
Age of child in years
Age + 12;
|
X Adult dose
|
d) Fried's Rule
Age in months
150
|
X Adult dose
|
Paediatric dose calculations based on body weight
A more reliable method of paediatric dose calculation than the preceding dosage
rules is the dosage on a given amount of drug per pound or kilogram of body weight.
NOTE: Round off all body weights in kilograms to the nearest whole number
Example: The parenteral dose of erythromycin injection is 10 mg/kg/24 hours. Calculate
the daily dose of this drug for a 44-pound child
Step1: Convert the weight of the child in Kgs
44 pounds
2.2
|
=
|
20 kilograms
|
Step2: Multiply client's weight by the dose
Child's dose = 20kgs X 10 mg/kg
=200mg/24 hrs
Paediatric dose calculations based on surface area
A newer and possibly more accurate method of paediatric dose calculation is based
on body surface area. Although this method is not as widely used or accepted as
calculations based on body weight, most if not all drugs may have their dosage expressed
per square meter of body surface area (m²). This method of relating the surface
area of individuals to dosage is simplified using a surface area nomogram in dose
calculations.
Example
The doctor has ordered an antibiotic whose average adult dose is 250 mg per day.
What would the dosage for this medication be on a child who has a length of 120
cm and weight of 40 kg?
First you must determine the BSA. One method is using the West Nomogram.
Using a straight edge (such as a ruler or piece of paper), align the straight edge
so it intersects at the child's height and weight. Doing so will create an intersection
in the BSA scale. The boxed in scale is to be used only if the child is of normal
height and weight.
Next, enter the BSA value of 1.2 (determined from nomogram) and the adult dose of
250 into the calculator
In this example, 173 mg of medication would be given
|
Formula: |
BSA
173
|
X
|
Adultdose
|
=
|
approximate child dosage.
|
Drugs Controller of India
The National Human Rights Commission(NHRC)has described the manufacture, distribution
and sale of unsafe drugs and medical devices as a violation of human rights.
The Drugs and Cosmetics Bill was passed by the Central Legislative Assembly and
it received the assent of the Governor General on 10th April, 1940 and thus became
the Drugs and Cosmetics Act, 1940.
The Drugs and Cosmetics Act, 1940 is a consumer protection legislation, which is
mainly concerned with the standards and quality of drugs and regulates the import,
manufacture, sale and distribution of drugs and cosmetics.